Results 121 to 130 of about 8,113 (209)

Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension). [PDF]

Pulm Circ
Jansa P, Sadushi-Kolici R, Skoro-Sajer N, Kopec G, Simkova I, Steringer-Mascherbauer R, Salobir B, Lindner J, Lang IM.   +8 more
europepmc   +1 more source

OUTCOME WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AFTER PATIENTS?? LISTING FOR TRANSPLANTATION: IMPACT OF ILOPROST AND BOSENTAN THERAPY.

, 2006
NULL AUTHOR_ID
openalex   +1 more source

Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease With and Without Down's Syndrome [PDF]

, 2009
M. G. J. Duffels, Jeroen C. Vis, Rosa Laura E. van Loon, Pythia T. Nieuwkerk, Arie P.J. van Dijk, Elke S. Hoendermis, Rianne H.A.C.M. de Bruin‐Bon, Berto J. Bouma, Paul Bresser, Rolf M.F. Berger, Barbara J.M. Mulder   +10 more
openalex   +1 more source

The specific medications for pulmonary arterial hypertension at functional class III to IV: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Li Q, Kuang H, Yi Q, Du H.
europepmc   +1 more source

Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis. [PDF]

RMD Open
Guédon AF, Carrat F, Mouthon L, Launay D, Chaigne B, Pugnet G, Lega JC, Hot A, Cottin V, Agard C, Allanore Y, Fauchais AL, Lescoat A, Dhote R, Papo T, Chatelus E, Bonnotte B, Kahn JE, Diot E, Aouba A, Magy-Bertrand N, Queyrel V, Le Quellec A, Kieffer P, Amoura Z, Granel B, Gaultier JB, Balquet MH, Wahl D, Lidove O, Espitia O, Cohen A, Fain O, Hachulla E, Mekinian A, Rivière S.   +35 more
europepmc   +1 more source

No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis [PDF]

, 2009
M. E. Hettema, Dan Zhang, Ymkje Stienstra, Andries J. Smit, Hendrika Bootsma, Cees G. M. Kallenberg   +5 more
openalex   +1 more source

Nova Retard: Bosentan

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2011
openaire   +2 more sources

Hoarseness as a Rare Symptom of Idiopathic Pulmonary Arterial Hypertension Due to Ortner Syndrome: A Case Report. [PDF]

Am J Case Rep
Jaxa-Kwiatkowska K, Janus M, Graczyk MM, Szabatowska K, Gościniak W, Sawczak F, Paluszkiewicz J, Woźniak P, Smukowska-Gorynia A, Mularek-Kubzdela T.   +9 more
europepmc   +1 more source

Bosentan (Tracleer®)

Pharmaceutisch Weekblad, 2004
Wilting, I., van den Bemt, P.M.L.A., Lammers, E.   +2 more
openaire   +2 more sources

Increased circulating Endothelin-1 is a risk factor for ECMO use and mortality in neonates with congenital diaphragmatic hernia: a prospective observational study. [PDF]

Respir Res
Lemloh L, de Vadder A, Melaku T, Bo B, Patel N, Holdenrieder S, Mueller A, Kipfmueller F.   +7 more
europepmc   +1 more source